Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Beam Therapeutics Inc (BEAM)

Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,108,808
  • Shares Outstanding, K 82,311
  • Annual Sales, $ 377,710 K
  • Annual Income, $ -132,530 K
  • 60-Month Beta 1.88
  • Price/Sales 5.86
  • Price/Cash Flow N/A
  • Price/Book 2.33
Trade BEAM with:

Options Overview Details

View History
  • Implied Volatility 81.35% ( +8.78%)
  • Historical Volatility 54.73%
  • IV Percentile 93%
  • IV Rank 83.81%
  • IV High 90.25% on 02/27/24
  • IV Low 35.30% on 05/31/24
  • Put/Call Vol Ratio 0.70
  • Today's Volume 685
  • Volume Avg (30-Day) 283
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 13,818
  • Open Int (30-Day) 13,026

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -1.13
  • Number of Estimates 7
  • High Estimate -0.91
  • Low Estimate -1.28
  • Prior Year -1.08
  • Growth Rate Est. (year over year) -4.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.25 +21.17%
on 07/02/24
27.62 -2.39%
on 07/12/24
+2.09 (+8.40%)
since 06/14/24
3-Month
20.84 +29.37%
on 04/25/24
27.76 -2.88%
on 06/12/24
+1.26 (+4.90%)
since 04/16/24
52-Week
16.95 +59.06%
on 10/23/23
49.50 -45.54%
on 02/27/24
-3.90 (-12.64%)
since 07/14/23

Most Recent Stories

More News
3 Cathie Wood Biotech Stocks That Analysts Expect to Double

This article delves into three biotech stocks held in Cathie Wood's ARKK ETF that analysts expect to double in value. Investors looking to add exposure to promising biotech opportunities, with a preference...

ARKK : 49.52 (+3.82%)
NTLA : 27.33 (+5.07%)
PRME : 6.70 (+15.92%)
BEAM : 27.29 (+6.52%)
XBI : 101.85 (+1.95%)
WFC : 60.25 (+4.37%)
VKTX : 56.95 (-4.09%)
CRSP : 62.72 (+9.15%)
ABBV : 169.25 (+0.73%)
AMGN : 333.87 (+1.13%)
BMY : 41.13 (+2.44%)
GILD : 71.65 (+1.19%)
Why Beam Therapeutics Stock Zoomed 17% Higher Today

JPMorgan Chase becomes the latest institution in the company's bull pen.

VERV : 7.84 (+9.50%)
LLY : 941.11 (-0.98%)
BEAM : 27.29 (+6.52%)
JPM : 213.60 (+1.69%)
Stocks Set to Open Mixed as Investors Await Fed Meeting and Big Tech Earnings

March S&P 500 E-Mini futures (ESH24) are down -0.04%, and March Nasdaq 100 E-Mini futures (NQH24) are up +0.11% this morning as market participants braced for the Federal Reserve’s first monetary policy...

ESH24 : 5,101.67s (-1.01%)
NQH24 : 17,854.75s (-0.94%)
INTC : 34.36 (-0.29%)
KLAC : 867.24 (+1.06%)
WDC : 76.94 (-2.39%)
AXP : 249.64 (+2.31%)
MSFT : 449.51 (-0.98%)
GOOGL : 183.77 (-1.48%)
AAPL : 234.64 (+0.10%)
AMZN : 193.01 (+0.15%)
META : 489.65 (-1.31%)
AMD : 177.66 (-1.21%)
3 Incredible Growth Stocks That Could Soar in 2024, According to Wall Street

Analysts have high hopes for these three innovation companies in 2024.

BEAM : 27.29 (+6.52%)
EWTX : 22.20 (-2.93%)
GLUE : 4.88 (+16.47%)
4 Cathie Wood Stocks Wall Street Thinks Will Skyrocket 83% to 168% in 2024

Even if Wall Street is wrong about these stocks in the new year, Cathie Wood could still be right about them over the long run.

ARKK : 49.52 (+3.82%)
ARKW : 84.62 (+1.18%)
GH : 33.83 (+7.26%)
ARKG : 27.39 (+7.67%)
BEAM : 27.29 (+6.52%)
DNA : 0.3970 (+36.85%)
NTLA : 27.33 (+5.07%)
2 Cathie Wood Stocks That Could Soar in 2024, According to Wall Street

Wall Street is uber-bullish on these two Ark Invest holdings.

MASS : 6.18 (+11.75%)
BEAM : 27.29 (+6.52%)
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.

The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach.

CRSP : 62.72 (+9.15%)
BEAM : 27.29 (+6.52%)
CRBU : 2.69 (+26.29%)
EDIT : 5.95 (+6.06%)
NTLA : 27.33 (+5.07%)
PRME : 6.70 (+15.92%)
VERV : 7.84 (+9.50%)
LLY : 941.11 (-0.98%)
REGN : 1,094.28 (+1.12%)
VRTX : 488.88 (-0.40%)
ARKG : 27.39 (+7.67%)
HOOD : 24.62 (+2.84%)
Is Beam Therapeutics Stock a Buy Now?

It has plenty of money, but it'll be facing plenty of competition, too.

PFE : 29.42 (+1.10%)
BEAM : 27.29 (+6.52%)
3 Monster Stocks in the Making

These stocks could grow much larger over the next few years.

BEAM : 27.29 (+6.52%)
CRSP : 62.72 (+9.15%)
SRPT : 148.88 (-2.48%)
Right Now Could Be a Once-in-a-Generation Opportunity to Buy These Cathie Wood Stocks

You might not get a better chance to invest in these disruptive companies.

UBER : 74.35 (+2.85%)
TWLO : 59.99 (+3.08%)
BEAM : 27.29 (+6.52%)
VRTX : 488.88 (-0.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Beam Therapeutics Inc. is a biotechnology company. It engages in developing precision genetic medicines through base editing. Beam Therapeutics Inc. is based in Cambridge, Massachusetts.

See More

Key Turning Points

3rd Resistance Point 27.45
2nd Resistance Point 26.55
1st Resistance Point 26.09
Last Price 27.29
1st Support Level 24.73
2nd Support Level 23.83
3rd Support Level 23.37

See More

52-Week High 49.50
Fibonacci 61.8% 37.07
Fibonacci 50% 33.22
Fibonacci 38.2% 29.38
Last Price 27.29
52-Week Low 16.95

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar